Table 2.
Anthropometric and glyco-metabolic parameters at baseline and at 6 months after nutraceutical therapy
| Nutraceutical group | ||
|---|---|---|
| Baseline | 6 months | |
| N | 89 | 81 |
| Sex (M/F) | 40/49 | 38/43 |
| Age (years) | 63.9±10.3 | 63.4±10.1 |
| Weight (Kg) | 101.6±19.7 | 99.8±18.6 |
| WC (cm) | 108.3±10.4 | 102.7±9.3* |
| BMI (Kg/m2) | 27.3±2.2 | 26.9±1.9 |
| FPG (mg/dL) | 152.4±48.2 | 116.8±22.7**° |
| PPG (mg/dL) | 188.3±56.3 | 156.2±32.6**^ |
| HbA1c (%) | 7.4±1.6 | 6.6±1.2*^ |
| TC (mg/dL) | 179.6±20.8 | 172.8±18.2 |
| LDL-C (mg/dL) | 104.1±10.6 | 99.1±9.5 |
| HDL-C (mg/dL) | 41.5±6.8 | 42.6±7.1 |
| Tg (mg/dL) | 169.8±51.6 | 155.7±42.2 |
Notes: Data are expressed as mean ± standard deviation; *p<0.05 vs baseline; **p<0.01 vs baseline; ^p<0.05 vs placebo; °p<0.01 vs placebo.
Abbreviations: WC, waist circumference; BMI, body mass index; FPG, fasting plasma glucose; PPG, post-prandial plasma glucose; HbA1c, glycated hemoglobin; TC, total cholesterol; LDL-C, low-density lipoprotein-cholesterol; HDL-C, high-density lipoprotein-cholesterol; Tg, triglycerides.